ONA Therapeutics

ONA Therapeutics

Investigación biotecnológica

Barcelona, Catalonia 6567 seguidores

First-in-class ADCs tailor designed to attack advanced cancer

Sobre nosotros

Ona Therapeutics is pioneering the development of first-in-class antibody drug conjugates (ADCs) that exploit the molecular underpinnings of advanced cancer. We partner with renowned academics and clinicians to discover novel therapeutic targets from the unique biology of treatment refractory advanced cancer patients. Our approach combines privileged biology with Ona’s expertise in biologics. Together, we craft ADCs and antibody therapies, aiming to provide effective new treatments for patients with no remaining alternatives.

Sector
Investigación biotecnológica
Tamaño de la empresa
De 11 a 50 empleados
Sede
Barcelona, Catalonia
Tipo
De financiación privada
Fundación
2019

Ubicaciones

  • Principal

    Carrer de Baldiri Reixac, 4

    Barcelona, Catalonia 08028, ES

    Cómo llegar

Empleados en ONA Therapeutics

Actualizaciones

Páginas similares

Buscar empleos

Financiación

ONA Therapeutics 2 rondas en total

Última ronda

Serie A

33.799.504,00 US$

Ver más información en Crunchbase